Biogen
PulseAugur coverage of Biogen — every cluster mentioning Biogen across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
AI model detects hidden multiple sclerosis lesions
A new artificial intelligence model has been developed that can identify previously invisible lesions associated with multiple sclerosis. This AI-driven approach promises to enhance diagnostic capabilities and potential…
-
Glass substrate tech gains market focus amid company R&D updates; Biogen eyes RayThera acquisition
The market is showing increased interest in glass substrate technology, spurred by TSMC's development plan. Several companies, including XingSen Technology, Medi-Tech, Vogue Optoelectronics, and Qibin Group, have announ…
-
Boston Scientific to acquire RayThera for up to $1B; SpaceX overtakes Amazon · 1 source tracked
Boston Scientific is set to acquire RayThera for up to $1 billion, a move aimed at expanding Boston Scientific's pipeline of investigational immunology products. The deal includes an upfront payment and additional payme…
-
New AI method boosts drug property prediction accuracy
Researchers have developed a new pretraining framework called Probabilistic Contrastive Pretraining (PCP) to enhance the prediction of ADME properties crucial for drug discovery. This method combines chemistry-specific …
-
Kordata Dynamics launches neurotech platform for clinical trials
Kordata Dynamics has launched to address a $26 billion market in central nervous system (CNS) therapeutics by integrating neurotechnology into clinical trials. The company, a spinout from BIOS Health, will partner with …
-
GNNs enhanced for drug discovery via ECFP pre-training
Researchers have developed a new strategy to enhance Graph Neural Networks (GNNs) for drug discovery tasks like Quantitative Structure-Activity Relationship (QSAR) studies. This method involves pre-training GNNs to pred…